A BCMA/CD16A bispecific innate cell engager for the treatment of multiple myeloma
Satoko Kakiuchi-Kiyota, Thorsten Ross, Heidi Ackerly Wallweber, James R. Kiefer, Melissa M. Schutten, Adeyemi O. Adedeji, Hao Cai, Robert L. Hendricks, Sivan Cohen, Srividya Myneni, Luna Liu, Aaron Fullerton, Nicholas Corr, Lanlan Yu, Denise de Almeida Nagata, Shelly Zhong, Steven R. Leong, Ji Li, Rin Nakamura, Teiko Sumiyoshi, Jinze Li, Ayse Meric Ovacik, Bing Zheng, Mike Dillon, Christoph Spiess, Susanne Wingert, Erich Rajkovic, Kristina Ellwanger, Uwe Reusch, Andrew G. Polson
Topics & Concepts
TolerabilityDaratumumabCytotoxicityCancer researchLysisAntibodyImmunologyMonoclonal antibodyChemistryMolecular biologyBiologyIn vitroPharmacologyBiochemistryAdverse effectMultiple Myeloma Research and TreatmentsMonoclonal and Polyclonal Antibodies ResearchComplement system in diseases